SCHEMBL26114640

SCHEMBL26114640

COc1ccc(CN2CC(C(C)OS(C)(=O)=O)C2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.46
▸ GRM2 Q14416 1/20 0.45
▸ MMP1 P03956 1/20 0.43
▸ MMP13 P45452 1/20 0.43
▸ CMA1 P23946 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ TACR1 P25103 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KCNA5 P22460 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26119781 0.86 FAAH (0.44) POLBTACR1
SCHEMBL26116306 0.80 GAA (0.51) GAAGRM2MMP1MMP13CMA1
SCHEMBL9462353 0.77 GRM2 (0.46) GAAGRM2MMP1MMP13CMA1
SCHEMBL9462348 0.77 GRM2 (0.46) GAAGRM2MMP1MMP13CMA1
SCHEMBL16430045 0.73 KCNA5 (0.46) POLBMEN1KMT2AGSK3AGSK3B
SCHEMBL16430048 0.73 KCNA5 (0.46) POLBMEN1KMT2AGSK3AGSK3B
SCHEMBL9805556 0.71 GAA (0.43) GAAGRM2MMP1MMP13CMA1
SCHEMBL29136236 0.71 GRM2 (0.44) GRM2MMP1MMP13ALDH1A1SMN1; SMN2
SCHEMBL17648735 0.69 GAA (0.48) GAAGRM2MMP1MMP13CMA1
SCHEMBL15400067 0.69 GRM2 (0.52) GAAGRM2MMP1MMP13CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same WASHINGTON UNIVERISTY (US) 2025-09-23 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME WASHINGTON UNIVERSITY (US) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322667-A1 DIHYDROFOLATE SYNTHASE (DHFS) INHIBITING AGENTS AND METHODS OF MAKING AND USING SAME DHFR, DHPS, MTHFD1 GAA 733/4885GRM2 3818/4885MMP1 2444/4885
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same DHFR, DHPS, MTHFD1 GAA 733/4885GRM2 3818/4885MMP1 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback